Transdermally administered aliskiren

Details for Australian Patent Application No. 2009319658 (hide)

Owner Merck Canada Inc.

Inventors Toulmond, Sylvie; Kwong, Elizabeth; Macdonald, Dwight

Agent Spruson & Ferguson

Pub. Number AU-A-2009319658

PCT Pub. Number WO2010/060199

Priority 61/167,186 07.04.09 US; 61/117,732 25.11.08 US

Filing date 23 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/060199 Priority application(s): WO2010/060199

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319659-Bacteriophage compositions for treatment of bacterial infections

2009319652-Welding apparatus and methods for welding